Primary Hemostasis Disorders as a Cause of Heavy Menstrual Bleeding in Women of Reproductive Age

被引:1
|
作者
Kontogiannis, Athanasios [1 ]
Matsas, Alkis [1 ]
Valsami, Serena [2 ]
Livanou, Maria Effrosyni [1 ]
Panoskaltsis, Theodoros [1 ]
Christopoulos, Panagiotis [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Aretaie Hosp, Fac Med, Dept Obstet & Gynecol 2, Athens 11528, Greece
[2] Natl & Kapodistrian Univ Athens, Aretaie Hosp, Hematol Lab, Blood Bank, Athens 11528, Greece
关键词
abnormal uterine bleeding; heavy menstrual bleeding; menorrhagia; primary hemostasis disorders; bleeding disorders; VON-WILLEBRAND-DISEASE; PROSPECTIVE GLANZMANN THROMBASTHENIA; EHLERS-DANLOS-SYNDROME; WFH; 2021; GUIDELINES; JOINT HYPERMOBILITY; IMMUNE THROMBOCYTOPENIA; REGISTRY TREATMENT; MENORRHAGIA; MANAGEMENT; DIAGNOSIS;
D O I
10.3390/jcm12175702
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heavy menstrual bleeding (HMB) is a common clinical condition affecting adolescent and adult women and compromising their quality of life. Primary hemostasis disorders, affecting platelet plug formation, can be the underlying cause of HMB. They comprise a heterogeneous group of diseases with Von Willebrand disease (VWD) being the most commonly diagnosed; other disorders in this group that have been linked to HMB include (a) Glanzmann thrombasthenia, (b) Bernard-Soulier syndrome, (c) Hermansky-Pudlak syndrome, (d) immune thrombocytopenia (ITP), and (e) Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD). Diagnosing these diseases can be challenging, as the basic laboratory investigations can be within the normal range. Thus, identification of specific clinical features and a thorough hematologic workup can be very important, providing the correct diagnosis. Proper diagnosis of the underlying disorder is important, as management may vary accordingly. Although disease-specific management guidelines exist for some of these disorders such as VWD and ITP, due to the rarity of most primary hemostasis disorders, the best approach for the management of HMB in these women remains elusive. The goal of this study was to create an informative, comprehensive review of the primary hemostasis disorders that have been linked to HMB. This study provides a summary of the basic published information regarding epidemiology, pathophysiology, clinical phenotype, diagnosis, and treatment of HMB in those diseases and serves as a reference guide for further reading.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] Concurrent use of tranexamic acid and hormonal therapy: Management of heavy menstrual bleeding in women with inherited bleeding disorders
    Turan, Ozlem
    Epstein, Audrey
    Abdul-Kadir, Rezan
    HAEMOPHILIA, 2022, 28 : 94 - 95
  • [42] Validation of the Menstrual Pictogram in Women With Leiomyomata Associated With Heavy Menstrual Bleeding
    Lois Larsen
    Karin Coyne
    Kristof Chwalisz
    Reproductive Sciences, 2013, 20 : 680 - 687
  • [43] Outcomes after Intrauterine Device Insertion for Heavy Menstrual Bleeding in Young Women with and without Inherited Bleeding Disorders
    Rosenbaum, Lucy Emma
    Zia, Ayesha
    Stanek, Joseph R.
    Haamid, Fareeda W.
    Christian-Rancy, Myra
    Kendel, Nicole
    O'Brien, Sarah H.
    BLOOD, 2020, 136
  • [44] Differences in bleeding phenotype and provider interventions in postmenarchal adolescents when compared to adult women with bleeding disorders and heavy menstrual bleeding
    Srivaths, L. V.
    Zhang, Q. C.
    Byams, V. R.
    Dietrich, J. E.
    James, A. H.
    Kouides, P. A.
    Kulkarni, R.
    HAEMOPHILIA, 2018, 24 (01) : 63 - 69
  • [45] Endometrial Ossification: An Unusual Cause of Heavy Menstrual Bleeding (HMB)
    Poddar P.
    Chavan K.
    Saraogi R.M.
    Yadav P.
    The Journal of Obstetrics and Gynecology of India, 2016, 66 (Suppl 2) : 666 - 668
  • [46] Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series
    Beyer-Westendorf, Jan
    Michalski, Franziska
    Tittl, Luise
    Hauswald-Doerschel, Susann
    Marten, Sandra
    LANCET HAEMATOLOGY, 2016, 3 (10): : E480 - E488
  • [47] Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids
    Schlaff, William D.
    Ackerman, Ronald T.
    Al-Hendy, Ayman
    Archer, David F.
    Barnhart, Kurt T.
    Bradley, Linda D.
    Carr, Bruce R.
    Feinberg, Eve C.
    Hurtado, Sandra M.
    Kim, JinHee
    Liu, Ran
    Mabey, R. Garn, Jr.
    Owens, Charlotte D.
    Poindexter, Alfred
    Puscheck, Elizabeth E.
    Rodriguez-Ginorio, Henry
    Simon, James A.
    Soliman, Ahmed M.
    Stewart, Elizabeth A.
    Watts, Nelson B.
    Muneyyirci-Delale, Ozgul
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (04): : 328 - 340
  • [48] No increased systemic fibrinolysis in women with heavy menstrual bleeding
    Wiewel-Verschueren, S.
    Knol, H. M.
    Lisman, T.
    Bogchelman, D. H.
    Kluin-Nelemans, J. C.
    Van der Zee, A. G. J.
    Mulder, A. B.
    Meijer, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (09) : 1488 - 1493
  • [49] Keyhole hysterectomy is effective for women with heavy menstrual bleeding
    Cook, Rob
    Lyon-Maris, Johnny
    Davidson, Peter
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 368
  • [50] Angiogenesis mediators in women with idiopathic heavy menstrual bleeding
    Elkilani, Osama A.
    Soliman, Mohamed A.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 136 (03) : 280 - 284